Dexamethasone stimulates osteogenic differentiation in vertebral and femoral bone marrow cell cultures: Comparison of IGF-I gene expression

Journal of Cellular Biochemistry

Volumn 71, Issue 3, 1998, Pages 382-391

  Milne, Moira ^a   Quail, John M ^a   Baran, Daniel T ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bone marrow cell cultures; Dexamethasone; IGF I; Vertebrae

Indexed keywords

DEXAMETHASONE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; BONE GROWTH; BONE MARROW CELL; CELL DIFFERENTIATION; ENZYME ACTIVITY; FEMUR; GENE EXPRESSION REGULATION; GROWTH STIMULATION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; RAT; VERTEBRA;

ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, NORTHERN; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMUR; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; OSTEOBLASTS; OSTEOCALCIN; RATS; RATS, SPRAGUE-DAWLEY; SPINE; TIME FACTORS;

ANIMALIA;

EID: 0032401702     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19981201)71:3<382::AID-JCB7>3.0.CO;2-R     Document Type: Article

References (40)

1. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB (1990): Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 143:213-221.
2. Bellows CG, Aubin JE, Heersche JN (1987): Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. Endocrinology 121:1985-1992.
3. Bellows CG, Heersche JN, Aubin JE (1990): Determination of the capacity for proliferation and differentiation of osteoprogenitor cells in the presence and absence of dexamethasone. Dev Biol 140:132-138.
4. Beresford JN (1989): Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop 240:270-280.
5. Beresford JN, Graves SE, Smoothy CA (1993): Formation of mineralized nodules by bone derived cells in vitro: A model of bone formation? Am J Med Genet 45:163-178.
6. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994): Differentiation of human bone marrow osteogenic stromal cells in vitro: Induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
7. Chomczynski P, Sacchi N (1987): Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 162:156-159.
8. Civitelli R, Gonnelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988): Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82:1268-1274.
9. Delany AM, Canalis E (1995): Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cells. Endocrinology 136:4776-4781.
10. Diamond T, Nery L, Hales I (1991): Atherapeutic dilemma: Suppressive doses of thyroxine significantly reduce bone mineral measurements in both premenopausal and postmenopausal women with thyroid carcinoma. J Clin Endocrinol Metab 72:1184-1188.
11. Feinberg AP, Vogelstein B (1983): A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
12. Heersche JNM, Reimers S, Denkovski P, Bellows CG, Aubin JE (1993): "Heterogeneity of Osteoblasts In Vivo and In Vitro." Fourth International Symposium on Osteoporosis and Consensus Development Conference, 27 Mar-2 April, 1993, Hong Kong.
13. Herbertson A, Aubin JE (1995): Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures. J Bone Miner Res 10:285-294.
14. Ishida Y, Heersche JN (1997): Progesterone stimulates proliferation and differentiation of osteoprogenitor cells in bone cell populations derived from adult female but not from adult male rats. Bone 20:17-25.
15. Jenis LG, Ongphiphadhanakul B, Braverman LE, Stein GS, Lian JB, Lew R, Baran DT (1994): Responsiveness of gene expression markers of osteoblastic and osteoclastic activity to calcitonin in the appendicular and axial skeleton of the rat in vivo. Calcif Tissue Int 54:511-515.
16. Kasugai S, Todescan R Jr, Nagata T, Yao KL, Butler WT, Sodek J (1991): Expression of bone matrix proteins associated with mineralized tissue formation by adult rat bone marrow cells in vitro: Inductive effects of dexamethasone on the osteoblastic phenotype. J Cell Physiol 147: 111-120.
17. Leboy PS, Beresford JN, Devlin C, Owen ME (1991): Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures. J Cell Physiol 146:370-378.
18. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G (1989): Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A 86:1143-1147.
19. Malaval L, Gupta AK, Aubin JE (1995): Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures. Endocrinology 136:1411-1418.
20. Malaval L, Gupta AK, Liu F, Delmas PD, Aubin JE (1998): LIF, but not IL-6, regulates osteoprogenitor differentiation in rat calvaria cell cultures: Modulation by dexamethasone. J Bone Miner Res 13:175-184.
21. Malpe R, Baylink DJ, Linkhart TA, Wergedal JE, Mohan S (1997): Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. J Bone Miner Res 12:423-430.
22. Maniatopoulos C, Sodek J, Melcher AH (1988): Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 254:317-330.
23. McCarthy TL, Centrella M, Canalis E (1990): Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells. Endocrinology 126:1569-1575.
24. Milne M, Kang M-I, Quail JM, Baran DT (1998): Thyroid hormone excess increases insulin-like growth factor I transcripts in bone marrow cell cultures: Divergent effects on vertebral and femoral cell cultures. Endocrinology 139:2527-2534.
25. Murphy LJ, Bell GI, Duckworth ML, Friesen HG (1987): Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology 121:684-691.
26. Ongphiphadhanakul B, Alex S, Braverman LE, Baran DT (1992): Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: Effect of hypogonadism and calcitonin. J Bone Miner Res 7:1227-1231.
27. Ongphiphadhanakul B, Jenis LG, Braverman LE, Alex S, Stein GS, Lian JB, Baran DT (1993): Etidronate inhibits the thyroid hormone-induced bone loss in rats assessed by bone mineral density and messenger ribonucleic acid markers of osteoblast and osteoclast function. Endocrinology 133:2502-2507.
28. Owen M, Friedenstein AJ (1988): Stromal stem cells: Marrow-derived osteogenic precursors. In Evered D, Harnett S (eds): "Cell and Molecular Biology of Vertebrate Hard Tissues." New York: John Wiley & Sons, pp 42-71.
29. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990): Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
30. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I (1994): Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218-228.
31. 3 and the nonadherent cells of marrow for osteoblast differentiation from rat marrow stromal cells. Bone 16:671-678.
32. Shalhoub V, Conlon D, Tassinari M, Quinn C, Partridge N, Stein GS, Lian JB (1992): Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. J Cell Biochem 50:425-440.
33. Shalhoub V, Aslam F, Breen E, van Wijnen A, Bortell R, Stein GS, Stein JL, Lian JB (1998): Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: Glucocorticoid regulation of basal and vitamin D stimulated gene expression. J Cell Biochem 69:154-168.
34. Sharrock WJ (1998): Bone and the hematopoietic and immune systems: A report of the proceedings of a scientific workshop. J Bone Miner Res 13:537-543.
35. Stein GS, Lian JB (1993): Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 14:424-442.
36. Suwanwalaikorn S, Ongphiphadhanakul B, Braverman LE, Baran DT (1996): Differential responses of femoral and vertebral bones to long-term excessive L-thyroxine administration in adult rats. Eur J Endocrinol 134:655-659.
37. Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985): Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502.
38. Yao KL, Todescan R Jr, Sodek J (1994): Temporal changes in matrix protein synthesis and mRNA expression during mineralized tissue formation by adult rat bone marrow cells in culture. J Bone Miner Res 9:231-240.
39. Zhang RW, Simmons DJ, Crowther RS, Mohan S, Baylink DJ (1991): Contribution of marrow stromal cells to the regulation of osteoblast proliferation in rats: Evidence for the involvement of insulin-like growth factors. Bone Miner 13:201-215.
40. Zhang RW, Supowit SC, Xu X, Li H, Christensen MD, Lozano R, Simmons DJ (1995): Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma. Calcif Tissue Int 56:283-291.